Here are relevant reports on : live-streaming-content-creation-software-market
-
Entertainment Content and Goods Market Size, Share & Trends by Music Equipment and Memorabilia, Vinyl Record, Signed Merchandise, Lifestyle and Home Goods, Sporting Equipment, Collectible, Animated Content Creation, Film, TV/OTT and Apparel - Global Forecast to 2030
The entertainment content and goods market is expected to grow from USD 177.64 billion in 2025 to USD 239.52 billion by 2030, at a compound annual growth rate (CAGR) of 6.2% during the forecast period. The Key Players Walt Disney Company (US), Universal Music Group N.V. (Netherlands), Warner Music Group Inc. (US), Sony Music Entertainment (US), Paramount (US), Netflix, Inc. (US), Fanatics Inc. (US), DreamWorks Animation (US), Illumination (US), Amazon.com, Inc. (US), PUMA SE (Germany), New Era Cap (US), Adidas AG (Germany), Merchbar, Inc. (US), and Nike, Inc. (US).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Europe Content Delivery Network Market by Offering [Solutions (Web Performance Optimization, Media Delivery, Cloud Security) & Services], By Content Type (Static & Dynamic), By Application Area (Media & Entertainment, Online Gaming) - Forecast to 2030
The Europe content delivery network market is projected to reach USD 11.99 billion by 2030 from USD 7.75 billion in 2025, at a CAGR of 9.1%. The major vendors covered in the Europe content delivery network market are Akamai (United States), Cloudflare (United States), Fastly (United States), Amazon Web Services CloudFront (United States), Google Cloud CDN (United States), Microsoft Azure CDN (United States), CDN77 (Czech Republic), OVHcloud (France), Leaseweb (Netherlands), KeyCDN (Switzerland), Ateme (France), Bunny.net (Slovenia), CDNsun (Czech Republic), StreamZilla (Netherlands), Scaleway (France), and Gcore (Luxembourg).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
US Content Delivery Network Market by Offering [Solutions (Web Performance Optimization, Media Delivery, Cloud Security) & Services], Content Type (Static & Dynamic), Application Area (Media & Entertainment, Online Gaming) - Forecast to 2030
The US content delivery network market is expected to reach USD 9.77 billion by 2030 from USD 6.91 billion in 2025, at a CAGR of 7.2% during 2025–2030. Major vendors operating in the US content delivery network market include Akamai Technologies (US), Microsoft (US), IBM (US), Google (US), AWS (US), Cloudflare (US), Lumen Technologies (US), Fastly (US), Comcast Technologies (US), Rackspace Technology (US), Imperva (US), Quantil (US), StackPath (US), CacheFly (US), Edgio (US), Cox Edge (US), Fly.io (US), and Vultr (US).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2031
The human microbiome drugs market, valued at US$0.09 billion in 2024, stood at US$0.35 billion in 2025 and is projected to advance at a resilient CAGR of 35.2% from 2025 to 2031, culminating in a forecasted valuation of US$2.13 billion by the end of the period. The human microbiome drugs market is growing, driven by the increasing clinical success of live biotherapeutic products, rising prevalence of chronic and recurrent diseases, and expanding therapeutic applications beyond gastrointestinal disorders into metabolic, immune, and neurological conditions.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
IoT Device Management Market by Solution (Real-Time Streaming Analysis, Security Solutions, Data Management, Remote Monitoring, Network Bandwidth Management), Service, Application Area, Deployment Model, and Organization Size - Global Forecast to 2022
The IoT device management market size is expected to grow from USD 693.4 Million in 2017 to USD 2,559.6 Million by 2022, at a CAGR of 29.8% from 2017 to 2022. The growing penetration of heterogeneous smart devices and IoT sensors, mandates the critical need for reliable IoT device management platforms or solutions for device remote activation and provisioning, configuration and control, and its management. Converged device management platform offers a single platform to manage devices across multitude of domains and protocols for communication. IoT devices include heterogeneous stand-alone internet connected devices that need to be monitored and controlled from a remote location.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024
The live cell encapsulation market is projected to grow to USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2% during the forecast period. Growth in the live cell encapsulation market is primarily driven by factors such as the increasing public-private investments to support product development, increasing research to establish the clinical efficacy of cell encapsulation technologies, and rising public awareness related to the clinical role of encapsulated cells in disease management. BioTime, Inc. (US), Viacyte, Inc. (US), and Living Cell Technologies Ltd. (Australia) were the top three players in the live cell encapsulation market. Other prominent players operating in this market include Sigilon Therapeutics, Inc. (US), Evonik Industries (Germany), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), and Sernova Corporation (Canada), among others. Furthermore, the key players in the developmental pipeline products in this market include Neurotech Pharmaceuticals, Inc. (US), Gloriana Therapeutics (US), Kadimastem (Israel), Beta-O2 Technologies, Inc. (Israel), Defymed (France), and Altucell, Inc. (US), among others.
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Microscope Camera Market by Type (Color, Monochrome), Sensor (CMOS, CCD), Resolution (SD, HD, UHD), Application (Live Cell Imaging, Pathology, Pharmaceutical & Biopharmaceutical Research), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2029
The global microscope camera market, valued at US$178 million in 2023, stood at US$191 million in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$278 million by the end of the period. Growth in this market is mainly driven by factors such as the growing prevalence of chronic diseases and advancing technological aspects in microscope cameras. Growth opportunities in the Asia Pacific region are also expected to leverage a positive environment for players playing in the microscope camera market.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
US Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The US veterinary vaccines market, valued at USD4.39 billion in 2025, stood at USD4.67 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2031, culminating in a forecasted valuation of USD6.50 billion by the end of the period. This growth is attributed to the increasing awareness regarding animal health as well as the rising pet population and pet ownership. Other emerging trends affecting the growth of this segment are government initiatives to improve the health of animals and increased adoption of pet coverage.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Asia Pacific Vaccines market, valued at USD 9.46 billion in 2024, stood at USD 9.89 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of USD14.57 billion by the end of the period. The market is expanding quickly, driven by a rise in vaccine development and commercialization, heightened infectious disease rates, and the extensive use of preventive vaccines.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Europe Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Europe vaccines market, valued at US$10.53 billion in 2024, stood at US$9.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$13.74 billion by the end of the period. The vaccines market is growing due to fast global developments and the commercialization of vaccines, rising rates of infectious diseases, which require preventive measures, and government initiatives to encourage vaccinations, immunization programs, advancements, and investments in new vaccines against various diseases.
- Published: June 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
